8-K: Cigna Group Announces $3.2 Billion Accelerated Share Repurchase Program

The Cigna Group has entered into agreements to repurchase $3.2 billion of its common stock as part of its existing share repurchase program.

Summary

• The Cigna Group has entered into accelerated share repurchase agreements (ASR Agreements) with Deutsche Bank AG and Bank of America, N.A.
• Under these agreements, Cigna will repurchase $3.2 billion of its common stock.
• Cigna will receive an initial delivery of approximately 7.6 million shares on February 15, 2024, in exchange for a $3.2 billion prepayment.
• The final number of shares repurchased will be determined by the volume-weighted average price of Cigna's stock during the transaction period, less a discount.
• Final settlement of the ASR Agreements is expected in the second quarter of 2024.
• The company expects to repurchase $5 billion of common stock in the first half of 2024, including this accelerated repurchase.
• Cigna intends to use the majority of its discretionary cash flow for share repurchases this year.

Sentiment

Score: 8

Explanation: The announcement of a significant share repurchase program is generally viewed positively by investors, indicating management's confidence in the company's financial health and future prospects. The program is also expected and in line with previous guidance.

Positives

• The accelerated share repurchase program demonstrates Cigna's commitment to returning value to shareholders.
• The repurchase program is a value-enhancing deployment of capital.
• The company's strong business performance allows for significant share repurchases.
• The company is on track to repurchase $5 billion of common stock in the first half of 2024.

Risks

• The final number of shares repurchased is subject to market fluctuations and adjustments.
• The ASR Agreements contain provisions that could lead to adjustments in the transaction terms.
• The company may be required to make a cash payment or deliver additional shares at final settlement under certain circumstances.
• Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.

Future Outlook

Cigna expects to repurchase $5 billion of common stock in the first half of 2024 and intends to use the majority of its discretionary cash flow for share repurchases this year.

Management Comments

• David M. Cordani, Chairman and Chief Executive Officer, stated that the accelerated share repurchase represents a value-enhancing deployment of capital.
• Cordani also noted that this is a testament to the ongoing growth and strength of their businesses, and they remain committed to returning significant value to their shareholders and investing in their future.

Industry Context

Share repurchases are a common method for companies to return capital to shareholders, especially when they believe their stock is undervalued. This move by Cigna is consistent with trends in the healthcare industry where companies with strong cash flows often engage in buybacks.

Comparison to Industry Standards

• Many large cap healthcare companies such as UnitedHealth Group (UNH) and CVS Health (CVS) also engage in share repurchase programs as a way to return capital to shareholders.
• The size of Cigna's repurchase program, at $3.2 billion, is significant and comparable to other large buyback programs in the sector.
• The use of accelerated share repurchase agreements is a common practice for large buybacks, allowing companies to quickly reduce their share count.
• Cigna's commitment to using the majority of its discretionary cash flow for share repurchases is a strong signal to investors about the company's confidence in its future performance.

Related Party Transactions

• The Dealers, Deutsche Bank AG and Bank of America, N.A., perform normal banking, investment banking and/or advisory services for Cigna from time to time for which they receive customary fees and expenses.

Stakeholder Impact

• Shareholders will benefit from the share repurchase program through increased earnings per share and potentially higher stock prices.
• The company's commitment to share repurchases signals confidence in its future performance, which can positively impact investor sentiment.
• The company's financial strength is reinforced by its ability to execute such a large buyback program.

Next Steps

• Final settlement of the ASR Agreements is expected to occur during the second quarter of 2024.
• The company will continue to repurchase shares throughout the year.

Key Dates

Keywords

share repurchase, accelerated share repurchase, ASR Agreements, common stock, capital deployment, shareholder value, stock buyback